| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.081 | 0.09 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.09 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |